OpenEvidence and Penn Medicine announced a global partnership on September 15, 2026, to bring AI-powered clinical decision support to Penn Medicine's more than 10,000 clinicians across its seven-hospital health system, with that support also extending to low- and middle-income countries through the Botswana-UPenn Partnership. Under the agreement, OpenEvidence's tools will be accessible to clinicians within the campuses of Penn Medicine and the Botswana-UPenn Partnership. The partners describe…
This article has been indexed from Unite.AI
Read the original article: